Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion

Virology

Volumn 350, Issue 2, 2006, Pages 406-417

  Ou, Wu ^a   Silver, Jonathan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Fusion; HIV 1; Protein disulfide isomerase; siRNA; Thioredoxin

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); CD4 ANTIGEN; ENVELOPE PROTEIN; PROTEIN DISULFIDE ISOMERASE; SMALL INTERFERING RNA; THIOREDOXIN;

ARTICLE; CELL FUSION; DISULFIDE BOND; DOWN REGULATION; EMBRYO; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; WILD TYPE;

BASE SEQUENCE; CELL FUSION; CELL LINE; DNA PRIMERS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN DISULFIDE-ISOMERASE; RNA, SMALL INTERFERING; SULFHYDRYL COMPOUNDS; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745236040     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.01.041     Document Type: Article

References (41)

1. Barbouche R., Miquelis R., Jones I.M., and Fenouillet E. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J. Biol. Chem. 278 (2003) 3131-3136
2. Barbouche R., Lortat-Jacob H., Jones I.M., and Fenouillet E. Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env. Mol. Pharmacol. 67 (2005) 1111-1118
3. Connor R.I., Chen B.K., Choe S., and Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206 (1995) 935-944
4. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
5. Essex D.W., and Li M. A polyclonal antibody to protein disulfide isomerase induces platelet aggregation and secretion. Thromb. Res. 96 (1999) 445-450
6. Felser J.M., Klimkait T., and Silver J. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations. Virology 170 (1989) 566-570
7. Fenouillet E., Barbouche R., Courageot J., and Miquelis R. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding. J. Infect. Dis. 183 (2001) 744-752
8. Gallina A., Hanley T.M., Mandel R., Trahey M., Broder C.C., Viglianti G.A., and Ryser H.J. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J. Biol. Chem. 277 (2002) 50579-50588
9. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A., Rawat S.S., Puri A., Durell S., and Blumenthal R. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614 (2003) 36-50
10. Garlick R.L., Kirschner R.J., Eckenrode F.M., Tarpley W.G., and Tomich C.S. Escherichia coli expression, purification, and biological activity of a truncated soluble CD4. AIDS Res. Hum. Retroviruses 6 (1990) 465-479
11. Greenberg M., Cammack N., Salgo M., and Smiley L. HIV fusion and its inhibition in antiretroviral therapy. Rev. Med. Virol. 14 (2004) 321-337
12. Hawkins H.C., and Freedman R.B. The reactivities and ionization properties of the active-site dithiol groups of mammalian protein disulphide-isomerase. Biochem. J. 275 Pt 2 (1991) 335-339
13. He J., Choe S., Walker R., Di M.P., Morgan D.O., and Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69 (1995) 6705-6711
14. Keller P., Toomre D., Diaz E., White J., and Simons K. Multicolour imaging of post-Golgi sorting and trafficking in live cells. Nat. Cell Biol. 3 (2001) 140-149
15. Kozak S.L., Heard J.M., and Kabat D. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76 (2002) 1802-1815
16. Liao Z., Graham D.R., and Hildreth J.E. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res. Hum. Retroviruses 19 (2003) 675-687
17. Lu X., Xiong Y., and Silver J. Asymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus. J. Virol. 76 (2002) 6701-6709
18. Markovic I., Stantchev T.S., Fields K.H., Tiffany L.J., Tomic M., Weiss C.D., Broder C.C., Strebel K., and Clouse K.A. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood 103 (2004) 1586-1594
19. Matthias L.J., Yam P.T., Jiang X.M., Vandegraaff N., Li P., Poumbourios P., Donoghue N., and Hogg P.J. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat. Immunol. 3 (2002) 727-732
20. Moore J.P., and Doms R.W. The entry of entry inhibitors: a fusion of science and medicine. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10598-10602
21. Mou Y., Ni H., and Wilkins J.A. The selective inhibition of beta 1 and beta 7 integrin-mediated lymphocyte adhesion by bacitracin. J. Immunol. 161 (1998) 6323-6329
22. Noiva R. Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. Semin. Cell. Dev. Biol. 10 (1999) 481-493
23. O'Neill S., Robinson A., Deering A., Ryan M., Fitzgerald D.J., and Moran N. The platelet integrin alpha IIbbeta 3 has an endogenous thiol isomerase activity. J. Biol. Chem. 275 (2000) 36984-36990
24. Ou W., Xiong Y., and Silver J. Quantification of virus-envelope-mediated cell fusion using a tetracycline transcriptional transactivator: fusion does not correlate with syncytium formation. Virology 324 (2004) 263-272
25. Popik W., and Alce T.M. CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J. Biol. Chem. 279 (2004) 704-712
26. Rawat S.S., Viard M., Gallo S.A., Rein A., Blumenthal R., and Puri A. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol. Membr. Biol. 20 (2003) 243-254
27. Ryser H.J., and Fluckiger R. Progress in targeting HIV-1 entry. Drug Discov. Today 10 (2005) 1085-1094
28. Ryser H.J., Levy E.M., Mandel R., and DiSciullo G.J. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4559-4563
29. Simons K., and Vaz W.L. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 269-295
30. Spenlehauer C., Gordon C.A., Trkola A., and Moore J.P. A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1. Virology 280 (2001) 292-300
31. Trkola A., Matthews J., Gordon C., Ketas T., and Moore J.P. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J. Virol. 73 (1999) 8966-8974
32. Turano C., Coppari S., Altieri F., and Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J. Cell. Physiol. 193 (2002) 154-163
33. Vodicka M.A., Goh W.C., Wu L.I., Rogel M.E., Bartz S.R., Schweickart V.L., Raport C.J., and Emerman M. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 233 (1997) 193-198
34. Vuori K., Myllyla R., Pihlajaniemi T., and Kivirikko K.I. Expression and site-directed mutagenesis of human protein disulfide isomerase in Escherichia coli. This multifunctional polypeptide has two independently acting catalytic sites for the isomerase activity. J. Biol. Chem. 267 (1992) 7211-7214
35. Vuori K., Pihlajaniemi T., Marttila M., and Kivirikko K.I. Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7467-7470
36. Wallin M., Ekstrom M., and Garoff H. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J. 23 (2004) 54-65
37. Wallin M., Ekstrom M., and Garoff H. The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization. J. Virol. 79 (2005) 1678-1685
38. Wang C.C. Protein disulfide isomerase assists protein folding as both an isomerase and a chaperone. Ann. N. Y. Acad. Sci. 864 (1998) 9-13
39. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., and Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46 (2002) 1896-1905
40. Werner A., and Levy J.A. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. J. Virol. 67 (1993) 2566-2574
41. Wilkinson B., and Gilbert H.F. Protein disulfide isomerase. Biochim. Biophys. Acta 1699 (2004) 35-44